Showing results (971-980 of 4,874) with videos related to

Sort By:
Pageof 488
Urologic Oncology|July 14, 2020
Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studiesChristina Santella, Julie Rouette, Michael D Brundage, et al.
Urologic Oncology|August 3, 2020
Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancerStephen J Freedland, Dominic Pilon, Rachel H Bhak, et al.
Urologic Oncology|August 12, 2020
Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experienceAlice Dragomir, Sara Nazha, Lori A Wood, et al.
Urologic Oncology|August 12, 2020
Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomesVictor Gaillard, Thibault Tricard, Julien Garnon, et al.
Urologic Oncology|February 26, 2022
Prognostic value of circulating tumor cells and immune-inflammatory cells in patients with renal cell carcinomaYibing Guan, Fangshi Xu, Juanhua Tian, et al.
Urologic Oncology|January 14, 2014
Target ablation--image-guided therapy in prostate cancerArnaud Marien, Inderbir Gill, Osamu Ukimura, et al.
Urologic Oncology|May 21, 2014
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United StatesAndrea B Apolo, Joseph W Kim, Bernard H Bochner, et al.
Urologic Oncology|May 27, 2014
Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancerEinar F Sverrisson, Michael S Zens, Dennis Liang Fei, et al.
Urologic Oncology|May 27, 2014
Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomyAtiqullah Aziz, Hans-Martin Fritsche, Georgios Gakis, et al.
Urologic Oncology|January 29, 2014
Expression profile of CD44s, CD44v6, and CD44v10 in localized prostate cancer: effect on prognostic outcomes following radical prostatectomyHiromoto Tei, Hideaki Miyake, Ken-ichi Harada, et al.
Pageof 488